Ironwood (IRWD) Reports Q1 2026 Earnings
Ironwood reported strong financial results for the first quarter of 2026, with significant growth in LINZESS U.S. net sales and total revenue. The company also announced progress on regulatory approvals and provided updated guidance for full-year performance.
Tickers: $IRWD
Topics: debt repayment plan FDA approval progress LINZESS sales growth pharmaceuticals